Fineline Cube

Follow:
14436 Articles
Hansoh Pharma Gains NMPA Clinical Approvals for HS-10510, HS-10542, and HS-20118
CompanyDrug

Hansoh Pharma Gains NMPA Clinical Approvals for HS-10510, HS-10542, and HS-20118

Genor Biopharma Gains NMPA Approval for CDK4/6 Inhibitor Lerociclib in China
CompanyDrug

Genor Biopharma Gains NMPA Approval for CDK4/6 Inhibitor Lerociclib in China

Astellas Pharma Licenses Evopoint's CLDN18.2 ADC for Global Development
CompanyDeals

Astellas Pharma Licenses Evopoint’s CLDN18.2 ADC for Global Development

Danaher Partners with AstraZeneca to Advance Precision Medicine
CompanyDeals

Danaher Partners with AstraZeneca to Advance Precision Medicine

Innovent Biologics Doses First Patient in Phase III Psoriasis Trial for Picankibart
CompanyDrug

Innovent Biologics Doses First Patient in Phase III Psoriasis Trial for Picankibart

GSK Halts PIVOT-PO Trial Early as Tebipenem HBr Meets Efficacy Targets for cUTI
CompanyDrug

GSK Halts PIVOT-PO Trial Early as Tebipenem HBr Meets Efficacy Targets for cUTI

Amoytop Biotech Wins NMPA Approval for Weekly Inpegsomatropin in Pediatric Growth Deficiency
CompanyDrug

Amoytop Biotech Wins NMPA Approval for Weekly Inpegsomatropin in Pediatric Growth Deficiency

Regend Therapeutics Gains NMPA Approval for Phase I/II Study of REGEND003 in Diabetes-Related CKD
CompanyDrug

Regend Therapeutics Gains NMPA Approval for Phase I/II Study of REGEND003 in Diabetes-Related CKD

Ganzhou Hemay Pharma Files for HK IPO with SDIC Securities Sponsorship
CompanyDeals

Ganzhou Hemay Pharma Files for HK IPO with SDIC Securities Sponsorship

GeneMind Biosciences Closes RMB 280 Million Series C+ Round to Fuel DNA Sequencer Innovation
CompanyDeals

GeneMind Biosciences Closes RMB 280 Million Series C+ Round to Fuel DNA Sequencer Innovation

Abbott Laboratories Receives FDA Approval for Tendyne TMVR System
CompanyMedical Device

Abbott Laboratories Receives FDA Approval for Tendyne TMVR System

AusperBio Secures $50M in Oversubscribed Series B+ Round to Advance Hepatitis B Therapy
CompanyDeals

AusperBio Secures $50M in Oversubscribed Series B+ Round to Advance Hepatitis B Therapy